1961 related articles for article (PubMed ID: 29119763)
1. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
2. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
Smith LA; Azariah F; Lavender VT; Stoner NS; Bettiol S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009464. PubMed ID: 26561338
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Whiting PF; Wolff RF; Deshpande S; Di Nisio M; Duffy S; Hernandez AV; Keurentjes JC; Lang S; Misso K; Ryder S; Schmidlkofer S; Westwood M; Kleijnen J
JAMA; 2015 Jun 23-30; 313(24):2456-73. PubMed ID: 26103030
[TBL] [Abstract][Full Text] [Related]
5. Herbal medicinal products or preparations for neuropathic pain.
Boyd A; Bleakley C; Hurley DA; Gill C; Hannon-Fletcher M; Bell P; McDonough S
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD010528. PubMed ID: 30938843
[TBL] [Abstract][Full Text] [Related]
6. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
7. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
Krcevski-Skvarc N; Wells C; Häuser W
Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms.
Allan GM; Finley CR; Ton J; Perry D; Ramji J; Crawford K; Lindblad AJ; Korownyk C; Kolber MR
Can Fam Physician; 2018 Feb; 64(2):e78-e94. PubMed ID: 29449262
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.
Tafelski S; Häuser W; Schäfer M
Schmerz; 2016 Feb; 30(1):14-24. PubMed ID: 26787227
[TBL] [Abstract][Full Text] [Related]
10. The cannabis paradox.
Ladouceur R
Can Fam Physician; 2018 Feb; 64(2):86. PubMed ID: 29449225
[No Abstract] [Full Text] [Related]
11. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.
Hill KP
JAMA; 2015 Jun 23-30; 313(24):2474-83. PubMed ID: 26103031
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting.
Gottlieb M; Carlson JN; Peksa GD
Cochrane Database Syst Rev; 2022 May; 5(5):CD013860. PubMed ID: 35588093
[TBL] [Abstract][Full Text] [Related]
13. [There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Basinski H; Jensen HB; Stenager E
Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350886
[TBL] [Abstract][Full Text] [Related]
14. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
Alderman B; Hui D; Mukhopadhyay S; Bouleuc C; Case AA; Amano K; Crawford GB; de Feo G; Sbrana A; Tanco K; To J; Garsed J; Davis M
Support Care Cancer; 2022 Dec; 31(1):39. PubMed ID: 36525085
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F; Enax-Krumova EK; Häuser W
Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.
Machado Rocha FC; Stéfano SC; De Cássia Haiek R; Rosa Oliveira LM; Da Silveira DX
Eur J Cancer Care (Engl); 2008 Sep; 17(5):431-43. PubMed ID: 18625004
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
Häuser W; Petzke F; Fitzcharles MA
Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533
[TBL] [Abstract][Full Text] [Related]
18. Medical use of cannabis: Italian and European legislation.
Zaami S; Di Luca A; Di Luca NM; Montanari Vergallo G
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1161-1167. PubMed ID: 29509270
[TBL] [Abstract][Full Text] [Related]
19. Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.
Furyk JS; Meek RA; Egerton-Warburton D
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010106. PubMed ID: 26411330
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Aviram J; Samuelly-Leichtag G
Pain Physician; 2017 Sep; 20(6):E755-E796. PubMed ID: 28934780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]